America's got a $250 billion hole in its pocket when trading with the EU. Wild, right?
Ever since WW2 wrapped up, Europe's been riding the wave of US goodwill. And here's the kicker – a massive chunk of that imbalance? Pharma patents and IP rights.
Europeans pay way less for drugs while Americans foot the bill. The pricing game isn't exactly fair play.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
8 Likes
Reward
8
4
Repost
Share
Comment
0/400
InscriptionGriller
· 15h ago
To put it bluntly, this is just the U.S. exploiting Europe, only under a fancier name called "trade deficit." The whole pharmaceutical patent game is something the old pros know well—it's still the same Ponzi scheme logic: whoever controls the pricing power is the one harvesting the profits.
View OriginalReply0
BearEatsAll
· 15h ago
Honestly, this huge price difference in medicine should have been addressed a long time ago.
View OriginalReply0
AllInDaddy
· 15h ago
Isn't this just a loophole created by the design of the US's own patent system?
View OriginalReply0
ETHmaxi_NoFilter
· 15h ago
To be honest, the price difference for this medication is just outrageous. Americans have been getting ripped off for so many years and still have no idea.
America's got a $250 billion hole in its pocket when trading with the EU. Wild, right?
Ever since WW2 wrapped up, Europe's been riding the wave of US goodwill. And here's the kicker – a massive chunk of that imbalance? Pharma patents and IP rights.
Europeans pay way less for drugs while Americans foot the bill. The pricing game isn't exactly fair play.